Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$789,547
+$56,422 QoQ
Shares Held
11,697
-41.0% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 211 holders
Holding Since
Jun 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. ANAB ranks #74 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in ANAB
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $789,547 | 11,697 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $733,125 | 13,219 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $281,620 | 5,809 | Shares | Defined | 2026-02-10 | |
| 2024-09-30 | $21,205 | 633 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $420,469 | 18,671 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $3,782,367 | 152,885 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $6,607,722 | 190,150 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,790,856 | 176,654 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,184,695 | 161,384 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,111,331 | 144,377 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $2,532,178 | 117,776 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,099,257 | 142,323 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $2,747,411 | 122,982 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||